Citation Impact
Citing Papers
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Cutaneous leishmaniasis: current and future management
2003
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis
2004
Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
1998
Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis.
1994
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
2023 StandoutNobel
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Inflammation and Alzheimer's disease
2000 Standout
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Control of phlebotomine sandflies
2003
Single‐Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study
2003
Leishmaniasis
2018 Standout
Trial of oral miltefosine for visceral leishmaniasis
1998
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study
2003
Reviews Of Anti‐infective Agents: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis
2006
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses
2014
Limited Effectiveness of High-Dose Liposomal Amphotericin B (AmBisome) for Treatment of Visceral Leishmaniasis in an Ethiopian Population With High HIV Prevalence
2011
Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin‐impregnated dog collars in southern Italy
2001
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
2014
Novel methods for liposome preparation
2013
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature
2005
A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience
2004
A review of stimuli-responsive nanocarriers for drug and gene delivery
2008 Standout
Cutaneous leishmaniasis
2007 Standout
Visceral leishmaniasis in HIV infected patients: Treatment with high dose liposomal amphotericin B (AmBisome)
1996
Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.
2002
The changing epidemiology of hepatitis C virus infection in Europe
2007
Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective
2017
HIV and the transmission ofLeishmania
2003
Liposomal Amphotericin B
1998
Liposomal amphotericin B: clinical experience and perspectives
2005
Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
2017
Chemotherapy in the Treatment and Control of Leishmaniasis
2006
Polymer conjugates as anticancer nanomedicines
2006 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Preparation of Large Monodisperse Vesicles
2009 StandoutNobel
Pediatric visceral leishmaniasis in southern France
1998
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995-2001)
2003
A leishmanin skin test survey in the human population of l'Alacantí Region (Spain): implications for the epidemiology of Leishmania infantum infection in southern Europe
2002
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
2005
Practical Guide for the Treatment of Leishmaniasis
1998
Treatment of leishmaniasis in HIV-positive patients
2003
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
3. Visceral leishmaniasis
2001
Global burden of liver disease: 2023 update
2023 Standout
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients
2001
Review: HIV infection and tropical parasitic diseases – deleterious interactions in both directions?
2002
Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B
1999
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
U.S. Food and Drug Administration Approval of AmBisome (Liposomal Amphotericin B) for Treatment of Visceral Leishmaniasis
1999
Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria
2006 Standout
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Designing dendrimers for biological applications
2005 Standout
Organic Switches for Surfaces and Devices
2012 StandoutNobel
Leishmania Induces Survival, Proliferation and Elevated Cellular dNTP Levels in Human Monocytes Promoting Acceleration of HIV Co-Infection
2012
pH-Responsive mechanised nanoparticles gated by semirotaxanes
2009 StandoutNobel
Control of Neglected Tropical Diseases
2007 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Liposomal amphotericin B as a treatment for human leishmaniasis
2012
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda
2002
Leishmaniasis
1999 Standout
The dawning era of polymer therapeutics
2003 Standout
Two Doses of a Lipid Formulation of Amphotericin B for the Treatment of Mediterranean Visceral Leishmaniasis
2003
Essential oils: From extraction to encapsulation
2015 Standout
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trialCommentary: cost and resistance remain issues
2001
Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
2019
Leishmania infantum : Lack of Parasite Resistance to Amphotericin B in a Clinically Resistant Visceral Leishmaniasis
1998
Epidemiology of the Leishmaniases
1995
Visceral Leishmaniasis Treatment, Italy
2003
Leishmania and human immunodeficiency virus coinfection: the first 10 years
1997
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Treatment options for visceral leishmaniasis
2006
Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis
2001
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Advances in leishmaniasis
2005 Standout
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years
1997
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
The Illusion of Sustainability
2007 StandoutNobel
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
Analysis of nanoparticle delivery to tumours
2016 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex
1998
Carrier effects on biological activity of amphotericin B
1996
Review : Synthetic Polymers with Intrinsic Anticancer Activity
1991
Drug Resistance in Leishmaniasis
2006 Standout
Polymeric materials based on silk proteins
2008 Standout
Works of R. Pempinello being referenced
The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typing
1993
Short-Course Treatment of Visceral Leishmaniasis with Liposomal Amphotericin B (AmBisome)
1996
Levels of Amoxycillin in the Liquor during Continuous Intravenous Administration
1982
Delta infection in the Naples area
1986
Recrudescence of visceral leishmaniasis unrelated to HIV infection in the Campania region of Italy
1996
Cerebrospinal fluid interleukin-6 and IgE in bacterial and viral meningitis.
1992
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial
1994
[Epidemiologic multicenter study of the prevalence of hepatitis in hospitalised immigrants in Italy in the year 2002].
2005